Ameritas Investment Partners’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,557
| Closed | -$689K | – | 3152 |
|
|
2025
Q4 | $689K | Buy |
9,557
+1,037
| +12% | +$67K | 0.02% | 727 |
|
|
2025
Q3 | $371K | Sell |
8,520
-3,091
| -27% | -$125K | 0.01% | 933 |
|
|
2025
Q2 | $330K | Hold |
11,611
| – | – | 0.01% | 1017 |
|
|
2025
Q1 | $343K | Hold |
11,611
| – | – | 0.01% | 969 |
|
|
2024
Q4 | $338K | Buy |
11,611
+666
| +6% | +$27.8K | 0.01% | 1011 |
|
|
2024
Q3 | $503K | Buy |
10,945
+1,042
| +11% | +$45.2K | 0.02% | 832 |
|
|
2024
Q2 | $405K | Buy |
9,903
+2,879
| +41% | +$82.6K | 0.01% | 883 |
|
|
2024
Q1 | $179K | Hold |
7,024
| – | – | 0.01% | 1357 |
|
|
2023
Q4 | $63.6K | Hold |
7,024
| – | – | ﹤0.01% | 2028 |
|
|
2023
Q3 | $44.8K | Buy |
7,024
+1,782
| +34% | +$15.4K | ﹤0.01% | 2171 |
|
|
2023
Q2 | $58.1K | Hold |
5,242
| – | – | ﹤0.01% | 1957 |
|
|
2023
Q1 | $80.5K | Buy |
5,242
+961
| +22% | +$21.1K | ﹤0.01% | 1676 |
|
|
2022
Q4 | $94.7K | Buy |
4,281
+614
| +17% | +$9.15K | ﹤0.01% | 1644 |
|
|
2022
Q3 | $59K | Hold |
3,667
| – | – | ﹤0.01% | 1859 |
|
|
2022
Q2 | $53K | Buy |
3,667
+780
| +27% | +$11.6K | ﹤0.01% | 1956 |
|
|
2022
Q1 | $53K | Hold |
2,887
| – | – | ﹤0.01% | 2034 |
|
|
2021
Q4 | $69K | Hold |
2,887
| – | – | ﹤0.01% | 1924 |
|
|
2021
Q3 | $71K | Buy |
2,887
+407
| +16% | +$8.85K | ﹤0.01% | 1919 |
|
|
2021
Q2 | $61K | Hold |
2,480
| – | – | ﹤0.01% | 2059 |
|
|
2021
Q1 | $54K | Buy |
2,480
+1,055
| +74% | +$25.8K | ﹤0.01% | 2041 |
|
|
2020
Q4 | $36K | Hold |
1,425
| – | – | ﹤0.01% | 2178 |
|
|
2020
Q3 | $40K | Buy |
+1,425
| New | +$41.2K | ﹤0.01% | 1978 |
|
Other funds holding RNAM
Ameritas Investment Partners's RNAM Position: Q1 2026 in Review
Ameritas Investment Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 9,557 shares — an estimated $689K sold.
Ameritas Investment Partners first reported a position in RNAM in Q3 2020 and held it in 22 quarters. The position peaked at $689K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Ameritas Investment Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Ameritas Investment Partners sold 9,557 Avidity Biosciences shares in Q1 2026, an estimated $689K.
- Ameritas Investment Partners first reported a position in Avidity Biosciences in Q3 2020 and held it in 22 quarters.
- Ameritas Investment Partners's Avidity Biosciences position peaked at $689K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.